Switching Long‐Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1‐Year <scp>OASISplus</scp> Results

20260 citationsJournal Articlehybrid Open Access

Authors

Marc A. Riedl · La Jolla Institute for Immunology

Jonathan A. Bernstein · Bernstein Clinical Research Center

Joshua S. Jacobs · Allergy, Asthma and Clinical Research Center

Timothy Craig · Vinmec International Hospital

William R. Lumry · Allergy Associates Research Center

H. James Wedner · Washington University in St. Louis

A. Banerji

Abstract

In patients who switched from another LTP, donidalorsen was well tolerated and improved long-term HAE attack rates, quality of life, and disease control.

Topics & Keywords

Coagulation, Bradykinin, Polyphosphates, and Angioedema Hemophilia Treatment and Research Complement system in diseases

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Allergy

DOI: 10.1111/all.70294

Field-Weighted Citation Impact: 0.00